Malonyl CoA inhibition of carnitine palmityltransferase in rat heart mitochondria  by Paulson, Dennis J. et al.
Volume 176, number 2 FEBS 1909 October 1984 
Malonyl CoA inhibition of carnitine palmityltransferase in
rat heart mitochondria 
Dennis J. Paulson, Karen M. Ward and Austin L. Shug* 
Metabolic Research Laboratory, William S. Middleton Memorial Veterans Hospital, 2500 Overlook Terrace, Madison, 
WI 53705, and Department of Neurology, University of Wisconsin-Madison, Madison, WI 53706, USA 
Received 27 July 1984 
The effects of malonyl CoA on carnitine palmityltransferase I (CPT-I), fatty acid-supported state 3 respira- 
tion, and carnitine reversal of palmityl CoA inhibition of state 3 respiration and of the adenine nucleotide 
translocator, were studied in isolated rat heart mitochondria. Malonyl CoA was a potent competitive inhibi- 
tor of CPT-I with an I,,, of 0.8 ,uM. Fasting did not affect CPT-I activity or the IS0 value of malonyl CoA. 
Malonyl CoA inhibited fatty acid-supported respiration and prevented carnitine from reversing the inhibi- 
tion of the adenine nucleotide translocator by palmityl CoA. These findings suggest hat malonyl CoA may 
affect fatty acid oxidation in the heart. 
Malonyl CoA Carnitine Palmityltransferase Mitochondria Fasting heart 
1. INTRODUCTION 
Malonyl CoA is a potent inhibitor of carnitine 
palmityltransferase-I (CPT-I), which catalyzes the 
reaction: 
changes in fasting or whether malonyl CoA will ac- 
tually affect mitochondrial oxidation of fatty acids 
by heart mitochondria. 
carnitine + palmityl CoA - 
palmitylcarnitine + CoA 
In the liver, it has been suggested that this reaction 
may regulate hepatic fatty acid oxidation and 
ketogenesis [l-3]. In fasted animals, hepatic 
malonyl CoA levels decrease, CPT-I activity is in- 
creased [4], and the inhibitory effect of malonyl 
CoA on fatty acid oxidation is decreased [5]. 
Malonyl CoA will also inhibit CPT-I in a number 
of extrahepatic tissues, including the heart [6]. 
Malonyl CoA is found in measurable amounts in 
heart and kidney; the levels decrease during fasting 
[3,7]. However, the role of malonyl CoA-CPT-I 
interaction in cardiac tissue is unclear. It is not 
known if CPT-I sensitivity to malonyl CoA 
Here, we determined the effects of malonyl CoA 
on (i) CPT-I activity of heart mitochondria 
isolated from fed and fasted rats, (ii) fatty acid- 
supported state 3 respiration, and (iii) carnitine 
reversal of palmityl CoA inhibition of state 3 
respiration and the adenine nucleotide 
translocator. 
2. MATERIALS AND METHODS 
* To whom correspondence should be addressed 
Rat heart mitochondria were isolated in medium 
containing 250 mM sucrose, 4 mM Tris (pH 7.4), 
1 mM EGTA, and 0.2% fatty acid-free bovine 
serum albumin [8]. Mitochondrial protein was 
measured by the biuret method 191, and respiratory 
activity determined on a Gilson 5/6 oxygraph [lo]. 
Adenine nucleotide translocator activity was quan- 
titatively determined by measuring the slower for- 
ward uptake of [14C]ATP at 2”C, using the car- 
boxyatractyloside inhibitor stop technique [8]. 
CPT-I activity was assayed using an isotope for- 
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ward reaction similar to that described in [ 111. Ap- 
prox. 30 mg of muscle was homogenized in 1 ml of 
isolation medium (300 mM sucrose, 5 mM Mops 
(pH 7.2) and 2 mM EDTA (pH 7.4)). A 0.05ml 
aliquot was removed and analyzed for non- 
collagenous protein. Another aliquot was 
freeze-thawed 3 times to disrupt mitochondrial 
membranes. 50- and 100-J aliquots were added to 
an incubation mixture containing 80 mM KCl, 
50 mM Mops (pH 7.2), 4 mM dithiothreitol, 
1 mg/ml albumin, 0.2 mM L-carnitine, 50pM 
palmityl CoA, and 0.78 &i DL-[‘4C]carnitine. 
The assay was run at 30°C for 7 min and ter- 
minated by adding 0.1 ml concentrated HCl. 
Palmitylcarnitine was extracted with 0.9 ml of 
butanol-saturated water and 1 ml butanol. The 
solution was vortex mixed and centrifuged. A 
0.75-ml portion was removed from the upper 
phase and extracted again. The radioactivity in a 
0.5-ml aliquot from this upper phase was counted 
using a Packard Tri-Carb liquid scintillation 
spectrometer. 
3. RESULTS AND DISCUSSION 
The effect of palmityl CoA and carnitine on rat 
heart mitochondrial CPT-I activity is shown in 
fig. 1. In the absence of malonyl CoA, the 
estimated K,,, values for palmityl CoA and car- 
nitine were 18 /cM and 0.6 mM, respectively. In the 
presence of 5 pM malonyl CoA, CPT-I activity 
was severely inhibited at the lower palmityl CoA 
concentrations and the substrate saturation curve 
for palmityl CoA became sigmoid. At higher con- 
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Fig.1. Effect of palmityl CoA and carnitine 
concentration on carnitine pahnityltransferase I (CPT-I) 
with and without 5 PM malonyl CoA in isolated rat 
heart mitochondria. (A) Pahnityl CoA concentration 
curve, with carnitine at 0.2 mM. (B) Carnitine 
concentration curve, with palmityl CoA at 50~M. 
centrations of palmityl CoA (60/1M), malonyl 
CoA (5 /IM) was not inhibitory, suggesting that the 
inhibition was competitive. The sigmoid curve pro- 
bably resulted from the interaction of varying 
amounts of palmityl CoA with the constant 
amount of bovine serum albumin in the reaction 
mixture. Malonyl CoA inhibited the carnitine 
substrate curve at all concentrations, suggesting 
that malonyl CoA does not competitively interact 
with camitine. 
Fig.2 shows the effect of varying malonyl CoA 
concentrations on the activity of CPT-I in heart 
mitochondria isolated from fed and 48-h-fasted 
rats. In contrast to results for liver [4,5], fasting 
did not increase CPT-I activity nor did it affect 
malonyl CoA inhibition of CPT-I. The ZOO value 
for heart mitochondria isolated from fed and 
fasted rats was 0.8 pM. This value is slightly higher 
than the ZSO for rat heart mitochondria found in 
[7], but it is still within the concentration range for 
malonyl CoA levels found in the heart. 
The effect of malonyl CoA on rat heart 
mitochondrial respiration is shown in table 1. 
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Fig.2. Effects of fasting on carnitine palmityltransfer- 
ase-I (CPT-I) sensitivity to inhibition by malonyl CoA in 
isolated rat heart mitochondria. Rats were fasted for 
48 h. Palmityl CoA and carnitine concentrations were 
SO/tM and 0.2 mM. 
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Table 1 
Effects of malonyl CoA on rat heart mitochondria state 3 respiration 
Substrate Malonyl CoA concentration (uM) 
Pyruvate + malate 
Pyruvate + malate + 
5 /rM palmityl CoA 
Pyruvate + malate + 
5 FM palmityl CoA + 
1 mM L-camitine 
5 ,uM pahnityl CoA + malate + 
2 mM L-camitine 
0 0.5 1.0 5.0 10.0 50.0 
314 - - - - 313 
90 80 80 100 80 79 
274 210 202 176 192 180 
144 - 94 58 72 36 
Results are expressed as natom oxygen/mg per min 
Malonyl CoA had no effect on pyruvate- and 
malate-supported state 3 respiration or on pahnityl 
CoA (5 FM) inhibition of this respiration. It did, 
however, prevent carnitine (1 mM) from reversing 
palmityl CoA inhibition. The effect of malonyl 
CoA was seen at a concentration as low as 0.5 pM, 
but the most effective concentration was 5 ,uM. 
Presumably, malonyl CoA inhibited CPT-I, which 
would prevent carnitine from reacting with 
pahnityl CoA to produce palmitylcarnitine plus 
free CoA. Palmityl CoA has been shown to inhibit 
the mitochondrial adenine nucleotide translocator 
[12,13], the transport protein that facilitates the 
exchange transport of cytosolic ADP for in- 
tramitochondrially produced ATP [ 141. It has been 
suggested to be one of the key steps and possibly 
the rate-limiting step in oxidative phosphorylation. 
Pahnitylcarnitine has no effect on this transport 
protein [12,13]. Table 1 also shows the effects of 
malonyl CoA on palmityl-CoA malate carnitine- 
supported state 3 respiration. The rate of respira- 
tion was less with these substrates than with 
pyruvate plus malate. Increasing concentrations of 
malonyl CoA produced a progressive decrease in 
oxygen uptake. 
We also determined the effect of palmityl CoA, 
carnitine, and malonyl CoA on a specific assay for 
the adenine nucleotide translocator (table 2). Addi- 
tion of 10 ,uM palmityl CoA inhibited this reaction 
by 32%. Carnitine (2 mM) partially reversed the 
inhibition, but 50/cM malonyl CoA completely 
prevented this reversal. 
In summary, these results show that malonyl 
CoA does not affect adenine nucleotide 
translocator activity, but it is a potent and relative- 
ly specific inhibitor of CPT-I and fatty acid- 
supported respiration of rat heart mitochondria. 
The malonyl CoA-CPT-I interaction may also be 
important in controlling mitochondrial respiration 
because of its effect on camitine reversal of 
palmityl CoA inhibition of the adenine nucleotide 
translocator. In contrast to liver CPT-I, heart 
CPT-I shows a sensitivity to malonyl CoA that is 
Table 2 
Effects of malonyl CoA on carnitine reversal of palmityl 
CoA inhibition of the mitochondrlal adenine nucleotide 
, translocator 
Pahnityl Camitine Malonyl 
CoA GM) (mM) CoA @M) 
Adenine 
nucleotide 
translocator 
(nmol/mg 
per min)” 
0 0 0 3.00 
5 0 0 2.78 
5 2 0 2.90 
5 2 50 2.76 
10 0 0 2.04 
10 2 0 2.25 
10 2 50 2.08 
* Values are the average of 2 experiments performed in 
triplicate 
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not affected by fasting. The levels of malonyl CoA 
that produce these effects are within the in vivo 
concentrations [7]. Although the precise role of 
malonyl CoA in the heart is still unclear, these 
results provide further evidence that maionyl CoA 
may exert a regulatory effect on fatty acid oxida- 
tion in the heart. Since fatty acids are the preferred 
substrate for the heart [ 1 !I], this reaction may be of 
particular importance. 
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